CT and MR manifestations of hepatoid adenocarcinoma of the pancreas: a case report and literature review_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

LI Xing ¹ , XIE Xin ² , LUI Su ¹ ,  LI Zhengyan ¹

1. Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding author：

LI Zhengyan, Email: 19932439@qq.com

Keywords：

pancreas; hepatoid adenocarcinoma; imaging signs; diagnosis

DOI：

10.7507/1007-9424.202310017

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Hepatoid adenocarcinoma (HAC) of the pancreas is a rare, highly malignant tumor with poor prognosis. This article presents the CT and MR features of HAC of the pancreas, while also reviewing the relevant literatures to succinctly summarize the underlying pathophysiological mechanism, imaging diagnosis, and differential diagnosis. The objective is to enhance the understanding of HAC of the pancreas among clinicians and radiologists.

Citation： LI Xing, XIE Xin, LUI Su, LI Zhengyan. CT and MR manifestations of hepatoid adenocarcinoma of the pancreas: a case report and literature review. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2024, 31(3): 297-300. doi: 10.7507/1007-9424.202310017 Copy

1.	Li M, Mei YX, Wen JH, et al. Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristics. Cancer Lett, 2023, 559: 216104.
2.	Kuo PC, Chen SC, Shyr YM, et al. Hepatoid carcinoma of the pancreas. World J Surg Oncol, 2015, 13: 185.
3.	Marchegiani G, Gareer H, Parisi A, et al. Pancreatic hepatoid carcinoma: a review of the literature. Dig Surg, 2013, 30(4-6): 425-433.
4.	Mattiolo P, Scarpa A, Luchini C. Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles. Hum Pathol, 2023, 132: 169-175.
5.	Lin JX, Wang ZK, Hong QQ, et al. Assessment of clinicopathological characteristics and development of an individualized prognostic model for patients with hepatoid adenocarcinoma of the stomach. JAMA Netw Open, 2021, 4(10): e2128217.
6.	Wang N, Kong R, Han W, et al. Aberrant β-catenin activity in hepatoid adenocarcinoma of the stomach. Curr Mol Med, 2021, 21(8): 655-664.
7.	Zhou K, Wang A, Ao S, et al. The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer, 2020, 20(1): 671.
8.	黄文鹏, 李莉明, 王芳, 等. 胰腺原发性肝样腺癌一例. 中华消化病与影像杂志(电子版), 2022, 12(5): 312-313.
9.	Yang Q, Liu Y, Zhang S. Hepatoid adenocarcinoma of the stomach: CT findings. Front Oncol, 2023, 13: 1036763.
10.	Dogeas E, Peng L, Choti M. Hepatoid adenocarcinoma of unknown primary masquerading as a pancreatic tumor. J Gastrointest Surg, 2017, 21(12): 2132-2134.
11.	Su JS, Chen YT, Wang RC, et al. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol, 19(3): 321-327.

1. Li M, Mei YX, Wen JH, et al. Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristics. Cancer Lett, 2023, 559: 216104.
2. Kuo PC, Chen SC, Shyr YM, et al. Hepatoid carcinoma of the pancreas. World J Surg Oncol, 2015, 13: 185.
3. Marchegiani G, Gareer H, Parisi A, et al. Pancreatic hepatoid carcinoma: a review of the literature. Dig Surg, 2013, 30(4-6): 425-433.
4. Mattiolo P, Scarpa A, Luchini C. Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles. Hum Pathol, 2023, 132: 169-175.
5. Lin JX, Wang ZK, Hong QQ, et al. Assessment of clinicopathological characteristics and development of an individualized prognostic model for patients with hepatoid adenocarcinoma of the stomach. JAMA Netw Open, 2021, 4(10): e2128217.
6. Wang N, Kong R, Han W, et al. Aberrant β-catenin activity in hepatoid adenocarcinoma of the stomach. Curr Mol Med, 2021, 21(8): 655-664.
7. Zhou K, Wang A, Ao S, et al. The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis. BMC Cancer, 2020, 20(1): 671.
8. 黄文鹏, 李莉明, 王芳, 等. 胰腺原发性肝样腺癌一例. 中华消化病与影像杂志(电子版), 2022, 12(5): 312-313.
9. Yang Q, Liu Y, Zhang S. Hepatoid adenocarcinoma of the stomach: CT findings. Front Oncol, 2023, 13: 1036763.
10. Dogeas E, Peng L, Choti M. Hepatoid adenocarcinoma of unknown primary masquerading as a pancreatic tumor. J Gastrointest Surg, 2017, 21(12): 2132-2134.
11. Su JS, Chen YT, Wang RC, et al. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol, 19(3): 321-327.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

CT and MR manifestations of hepatoid adenocarcinoma of the pancreas: a case report and literature review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content